Gillian M Keating

Summary

Publications

  1. doi request reprint Vorapaxar: a review of its use in the long-term secondary prevention of atherothrombotic events
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:797-808. 2015
  2. doi request reprint Alogliptin: a review of its use in patients with type 2 diabetes mellitus
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:777-96. 2015
  3. doi request reprint Canakinumab: a review of its use in the management of systemic juvenile idiopathic arthritis
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    BioDrugs 29:133-42. 2015
  4. doi request reprint Tiotropium Respimat(®): A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:809-16. 2015
  5. doi request reprint Olaparib: a review of its use as maintenance therapy in patients with ovarian cancer
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    BioDrugs 29:143-50. 2015
  6. doi request reprint Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:675-85. 2015
  7. doi request reprint Albiglutide: a review of its use in patients with type 2 diabetes mellitus
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:651-63. 2015
  8. doi request reprint Olodaterol: a review of its use in chronic obstructive pulmonary disease
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:665-73. 2015
  9. doi request reprint Teduglutide: a guide to its use in short bowel syndrome
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Clin Drug Investig 35:335-40. 2015
  10. doi request reprint Eltrombopag: a review of its use in patients with severe aplastic anaemia
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:525-31. 2015

Collaborators

Detail Information

Publications276 found, 100 shown here

  1. doi request reprint Vorapaxar: a review of its use in the long-term secondary prevention of atherothrombotic events
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:797-808. 2015
    ..Based on these results, vorapaxar has been approved in the EU as an adjunctive treatment for the secondary prevention of atherothrombotic events in patients with prior MI who do not have a history of stroke, TIA or ICH. ..
  2. doi request reprint Alogliptin: a review of its use in patients with type 2 diabetes mellitus
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:777-96. 2015
    ..In conclusion, alogliptin is a useful option for the treatment of patients with type 2 diabetes. ..
  3. doi request reprint Canakinumab: a review of its use in the management of systemic juvenile idiopathic arthritis
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    BioDrugs 29:133-42. 2015
    ..Thus, current evidence suggests subcutaneous canakinumab extends the treatment options currently available for patients aged ≥2 years with SJIA. ..
  4. doi request reprint Tiotropium Respimat(®): A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:809-16. 2015
    ..Thus, in patients with poorly controlled asthma despite receiving high-dose ICS and a LABA, tiotropium Respimat(®) provides a valuable treatment option. ..
  5. doi request reprint Olaparib: a review of its use as maintenance therapy in patients with ovarian cancer
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    BioDrugs 29:143-50. 2015
    ..An as yet unapproved tablet formulation of olaparib that has a lower pill burden than the capsule formulation is currently being investigated in phase III clinical studies. ..
  6. doi request reprint Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:675-85. 2015
    ..Oral ledipasvir/sofosbuvir was generally well tolerated. In conclusion, ledipasvir/sofosbuvir is an important new single-tablet regimen that represents a significant advance in the treatment of chronic hepatitis C. ..
  7. doi request reprint Albiglutide: a review of its use in patients with type 2 diabetes mellitus
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:651-63. 2015
    ..Thus, albiglutide is an effective and generally well tolerated treatment option for patients with inadequately controlled type 2 diabetes. ..
  8. doi request reprint Olodaterol: a review of its use in chronic obstructive pulmonary disease
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:665-73. 2015
    ..However, further longer-term and active comparator-controlled studies would be beneficial, including trials powered to assess COPD exacerbations. ..
  9. doi request reprint Teduglutide: a guide to its use in short bowel syndrome
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Clin Drug Investig 35:335-40. 2015
    ..Subcutaneous teduglutide was generally well tolerated in clinical trials, including over the long term, with most adverse events that led to study discontinuation being gastrointestinal in origin. ..
  10. doi request reprint Eltrombopag: a review of its use in patients with severe aplastic anaemia
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:525-31. 2015
    ..Eltrombopag was generally well tolerated, with increased liver transaminases as the only dose-limiting toxicity. Clonal cytogenetic abnormalities were observed in 19 % of patients and dysplasia in 5 % of patients. ..
  11. doi request reprint Daclatasvir: a review of its use in adult patients with chronic hepatitis C virus infection
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:515-24. 2015
    ..In conclusion, daclatasvir is a highly effective and well tolerated, oral, once-daily, direct-acting antiviral for use in combination therapy in adult patients chronically infected with HCV. ..
  12. doi request reprint Abacavir/Dolutegravir/Lamivudine Single-Tablet Regimen: A Review of Its Use in HIV-1 Infection
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:503-14. 2015
    ....
  13. doi request reprint Sucroferric oxyhydroxide: a review in hyperphosphataemia in chronic kidney disease patients undergoing dialysis
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:533-42. 2015
    ....
  14. doi request reprint Measles-Mumps-Rubella-Varicella Combination Vaccine (ProQuad(®)): A Guide to Its Use in Children in the EU
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Paediatr Drugs 17:167-74. 2015
    ....
  15. doi request reprint Lurasidone: a review of its use in adult patients with bipolar I depression
    Mark Sanford
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    CNS Drugs 29:253-63. 2015
    ..Thus, lurasidone offers a valuable addition to the therapies available for adult patients with bipolar depression, either as monotherapy or as an adjunct to lithium or valproate. ..
  16. doi request reprint Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:397-406. 2015
    ..The posaconazole IV solution provides an option for these same indications in patients who are unable to receive oral formulations. ..
  17. doi request reprint Fluticasone furoate/vilanterol: a review of its use in patients with asthma
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:407-18. 2015
    ..Thus, fluticasone furoate/vilanterol is an effective and generally well tolerated ICS/LABA option for the treatment of uncontrolled asthma. ..
  18. doi request reprint Naloxegol: a review of its use in patients with opioid-induced constipation
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:419-25. 2015
    ..Naloxegol is a useful option in the treatment of opioid-induced constipation. ..
  19. doi request reprint Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Target Oncol 10:171-8. 2015
    ..Although final overall survival data are awaited, current evidence suggests that sorafenib is a promising new treatment option for patients with RAI-refractory, metastatic DTC. ..
  20. doi request reprint Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:427-38. 2015
    ..In conclusion, febuxostat is a well established antihyperuricaemic agent that provides an effective alternative to allopurinol for the management of chronic gout. ..
  21. doi request reprint Brinzolamide/Brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs Aging 32:251-60. 2015
    ..Brinzolamide/brimonidine is the first available fixed-combination that does not contain timolol, and maybe particularly suited to patients with comorbidities that restrict treatment with β-adrenergic receptor antagonists. ..
  22. doi request reprint Gefitinib: a review of its use in adults with advanced non-small cell lung cancer
    Sohita Dhillon
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Target Oncol 10:153-70. 2015
    ....
  23. doi request reprint Enzalutamide: a review of its use in chemotherapy-naïve metastatic castration-resistant prostate cancer
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs Aging 32:243-9. 2015
    ..In conclusion, enzalutamide is a convenient, effective and well tolerated treatment for chemotherapy-naïve men with metastatic CRPC who are asymptomatic or mildly symptomatic. ..
  24. doi request reprint Idelalisib: a review of its use in chronic lymphocytic leukaemia and indolent non-Hodgkin's lymphoma
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Target Oncol 10:141-51. 2015
    ..In conclusion, idelalisib represents an important advance in the treatment of relapsed CLL and relapsed indolent NHL. ..
  25. doi request reprint Peginterferon beta-1a: a review of its use in patients with relapsing-remitting multiple sclerosis
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    CNS Drugs 29:171-9. 2015
    ....
  26. doi request reprint Obinutuzumab: a review of its use in patients with chronic lymphocytic leukaemia
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:285-96. 2015
    ....
  27. doi request reprint Ruxolitinib: a review of its use in patients with myelofibrosis
    Greg L Plosker
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:297-308. 2015
    ..Appropriate monitoring and dosage titration are important to achieve optimal clinical benefits of ruxolitinib. Further research, including studies evaluating ruxolitinib-based combination therapy, may also help to optimise treatment. ..
  28. doi request reprint Ticagrelor: a review of its use in adults with acute coronary syndromes
    Sohita Dhillon
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Am J Cardiovasc Drugs 15:51-68. 2015
    ....
  29. doi request reprint COBAS ® AmpliPrep/COBAS ® Taqman ® HCV Quantitative Test, version 2.0: an in vitro test for hepatitis C virus RNA quantification
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Mol Diagn Ther 19:1-7. 2015
    ..The test is not indicated for HCV infection diagnosis or to screen for the presence of HCV in blood/blood products. ..
  30. doi request reprint Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:309-20. 2015
    ..Tacrolimus PR is a promising addition to the treatment options available for kidney and liver transplant recipients...
  31. doi request reprint Silodosin: a review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:207-17. 2015
    ..In conclusion, silodosin is a useful option for the treatment of LUTS associated with BPH. ..
  32. doi request reprint Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:197-206. 2015
    ..More data are needed to confirm the longer-term efficacy of droxidopa. Droxidopa was generally well tolerated, although patients should be monitored for supine hypertension. ..
  33. doi request reprint Vedolizumab: a review of its use in adult patients with moderately to severely active ulcerative colitis or Crohn's disease
    K P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 29:57-67. 2015
    ..Vedolizumab is a useful addition to the treatment options available for patients with moderately to severely active ulcerative colitis and Crohn's disease. ..
  34. doi request reprint Pirfenidone: a review of its use in idiopathic pulmonary fibrosis
    Esther S Kim
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:219-30. 2015
    ..In conclusion, oral pirfenidone is a valuable agent for use in patients with IPF...
  35. doi request reprint Simeprevir: a review of its use in patients with chronic hepatitis C virus infection
    Mark Sanford
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:183-96. 2015
    ..Simeprevir is efficacious and generally well tolerated in patients with chronic HCV genotypes 1 and 4 infection. Studies of simeprevir in interferon-free regimens and in other subpopulations with HCV infections will be of interest...
  36. doi request reprint Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:175-82. 2015
    ..This article reviews the pharmacology of alipogene tiparvovec and its efficacy and safety in adults with LPLD...
  37. doi request reprint Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 28:1083-97. 2014
    ..Therefore, oral rasagiline is a valuable therapeutic option for use in all stages of Parkinson's disease. ..
  38. doi request reprint Linaclotide: a review of its use in the treatment of irritable bowel syndrome with constipation
    Paul L McCormack
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:53-60. 2014
    ..Linaclotide was generally well tolerated; the most common adverse event was diarrhoea. Thus, linaclotide is a novel and effective single agent for the treatment of IBS-C in adults...
  39. doi request reprint Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer
    Sheridan M Hoy
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:2077-91. 2013
    ..Although the final overall survival data in men with metastatic CRPC who have not previously received chemotherapy are awaited, current evidence indicates that abiraterone acetate is a useful option for the treatment of metastatic CRPC. ..
  40. doi request reprint Pramipexole extended-release: a review of its use in patients with Parkinson's disease
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2175-90. 2014
    ....
  41. doi request reprint Avanafil: a review of its use in patients with erectile dysfunction
    Mark Sanford
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs Aging 30:853-62. 2013
    ..During extended treatment with avanafil for >52 weeks, 2.8 % of patients discontinued treatment because of adverse reactions and there were no drug-related serious adverse events...
  42. doi request reprint Ivacaftor: a review of its use in patients with cystic fibrosis
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1595-604. 2013
    ..Thus, ivacaftor expands the current treatment options for patients with cystic fibrosis who have the G551D mutation. Its potential for use in patients with other CFTR mutations is also of interest. ..
  43. doi request reprint Dolutegravir: a review of its use in the management of HIV-1 infection in adolescents and adults
    Paul L McCormack
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1241-52. 2014
    ..Therefore, dolutegravir is an important new addition to the expanding list of antiretroviral drugs for treating HIV-1 infection in adults and adolescents. ..
  44. doi request reprint Sitagliptin: a review of its use in patients with type 2 diabetes mellitus
    Greg L Plosker
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:223-42. 2014
    ..A similar review is planned in the USA and postmarketing surveillance will continue. Thus, oral sitagliptin is an effective and generally well tolerated treatment option for the management of patients with type 2 diabetes. ..
  45. doi request reprint Epoprostenol (Veletri®, Caripul®): a review of its use in patients with pulmonary arterial hypertension
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Am J Cardiovasc Drugs 14:463-70. 2014
    ..Therefore, epoprostenol AS is a valuable therapeutic option that has the potential to overcome some of the limitations of long-term intravenous epoprostenol therapy in patients with PAH...
  46. doi request reprint Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:195-206. 2014
    ..Thus, cobicistat is an emerging alternative to ritonavir for the pharmacokinetic enhancement of PIs in adults with HIV-1 infection...
  47. doi request reprint Albumin-bound paclitaxel: a review of its use for the first-line combination treatment of metastatic pancreatic cancer
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1757-68. 2014
    ..Current evidence indicates that nab-paclitaxel plus gemcitabine is a valuable option for the treatment of metastatic pancreatic cancer. ..
  48. doi request reprint Dapagliflozin: a review of its use in patients with type 2 diabetes
    Greg L Plosker
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2191-209. 2014
    ....
  49. doi request reprint Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Clin Drug Investig 34:895-904. 2014
    ..In conclusion, defibrotide is the only agent approved (in the EU) for use in severe hepatic VOD following HSCT and represents a useful advance in the treatment of this condition. ..
  50. doi request reprint Fingolimod: a review of its use in relapsing-remitting multiple sclerosis
    Mark Sanford
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1411-33. 2014
    ..It has an acceptable tolerability profile and provides a useful alternative treatment in patients with RRMS who have responded poorly to other DMAs...
  51. doi request reprint Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:2161-74. 2014
    ..Thus, liraglutide continues to be a useful option for the management of type 2 diabetes. This article reviews the therapeutic use of liraglutide in adult patients with type 2 diabetes and summarizes its pharmacological properties. ..
  52. doi request reprint Tafamidis: a review of its use in familial amyloid polyneuropathy
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1371-8. 2014
    ..No new safety signals have emerged during long-term extension studies and post-marketing experience...
  53. doi request reprint Bosutinib: a review of its use in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
    Yahiya Y Syed
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    BioDrugs 28:107-20. 2014
    ..Therefore, bosutinib is a useful TKI option for patients with Ph+ CML in second-line or greater settings...
  54. doi request reprint Trastuzumab emtansine: a review of its use in patients with HER2-positive advanced breast cancer previously treated with trastuzumab-based therapy
    Sohita Dhillon
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:675-86. 2014
    ....
  55. doi request reprint Intravenous tocilizumab: a review of its use in adults with rheumatoid arthritis
    Sohita Dhillon
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    BioDrugs 28:75-106. 2014
    ....
  56. doi request reprint Macitentan: a review of its use in patients with pulmonary arterial hypertension
    Sohita Dhillon
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1495-507. 2014
    ....
  57. doi request reprint Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism
    Celeste B Burness
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:243-62. 2014
    ..In conclusion, rivaroxaban is a reasonable alternative to standard therapy for the treatment of DVT and PE, and as extended thromboprophylaxis...
  58. doi request reprint Ocriplasmin: a review of its use in patients with symptomatic vitreomacular adhesion
    Yahiya Y Syed
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1617-25. 2013
    ..Current evidence suggests that ocriplasmin is a useful treatment option for patients with symptomatic vitreomacular adhesion. ..
  59. doi request reprint Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence
    Gillian M Keating
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Clin Drug Investig 34:63-80. 2014
    ..In conclusion, sodium oxybate is a useful option for the treatment of alcohol withdrawal syndrome and for the maintenance of abstinence in alcohol dependence. ..
  60. doi request reprint Human immunoglobulin 10 % with recombinant human hyaluronidase: replacement therapy in patients with primary immunodeficiency disorders
    Mark Sanford
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 28:411-20. 2014
    ..Most patients preferred IGHy over intravenous administration. IGHy offers a new method for subcutaneous delivery of human immunoglobulin replacement therapy in patients with PIDs...
  61. doi request reprint Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis
    James E Frampton
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Paediatr Drugs 15:515-31. 2013
    ..Clinical laboratory abnormalities included neutropenia and elevated aminotransferase levels. The tolerability profile of tocilizumab in CHERISH was generally consistent with that of the drug in TENDER. ..
  62. doi request reprint Denosumab: a review of its use in postmenopausal women with osteoporosis
    Lesley J Scott
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs Aging 31:555-76. 2014
    ....
  63. doi request reprint Aripiprazole (ABILIFY MAINTENA®): a review of its use as maintenance treatment for adult patients with schizophrenia
    Matt Shirley
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1097-110. 2014
    ..It may be of particular use for patients stable on oral aripiprazole who would prefer, or are likely to benefit from, a long-acting formulation. ..
  64. doi request reprint Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer
    Lily P H Yang
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
    Mol Diagn Ther 18:105-16. 2014
    ..Although its impact on disease progression and survival rates is not yet known, HAL-BLC is a valuable addition to WLC for the diagnosis of bladder cancer in patients who are suitable candidates for its use. ..
  65. doi request reprint Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria
    Gillian M Keating
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1951-66. 2013
    ..g. diarrhoea, nausea) reported most commonly. In conclusion, single-dose fosfomycin trometamol is an important option for the first-line empirical treatment of uncomplicated lower UTIs. ..
  66. doi request reprint Certolizumab pegol: a review of its use in patients with axial spondyloarthritis or psoriatic arthritis
    Sohita Dhillon
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:999-1016. 2014
    ....
  67. doi request reprint Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension
    Mark Sanford
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Clin Drug Investig 34:521-8. 2014
    ..PF latanoprost offers a useful alternative to the available preserved prostaglandin analogues for the treatment of POAG/ocular hypertension...
  68. doi request reprint Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis
    Yahiya Y Syed
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:563-78. 2014
    ..Thus, add-on THC/CBD is a useful symptomatic treatment option for its approved indication...
  69. doi request reprint Exenatide twice daily: a review of its use in the management of patients with type 2 diabetes mellitus
    Paul L McCormack
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:325-51. 2014
    ..Thus, adjunctive exenatide twice daily is a valuable option in the treatment of type 2 diabetes inadequately controlled with OADs and/or basal insulin. ..
  70. doi request reprint Darunavir: a review of its use in the management of HIV-1 infection
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901 Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:99-125. 2014
    ..Thus, boosted darunavir is a useful option for the ART regimens of adult and paediatric patients with HIV-1 infection. ..
  71. doi request reprint 13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents
    Greg L Plosker
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Paediatr Drugs 15:403-23. 2013
    ....
  72. doi request reprint Rivaroxaban: a review of its use in acute coronary syndromes
    Greg L Plosker
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:451-64. 2014
    ..5 mg twice daily co-administered with aspirin alone or aspirin plus either clopidogrel or ticlopidine in patients with a recent ACS. ..
  73. doi request reprint QVA149 (indacaterol/glycopyrronium fixed-dose combination): a review of its use in patients with chronic obstructive pulmonary disease
    James E Frampton
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:465-88. 2014
    ..Therefore, it is a valuable option in the treatment of COPD. ..
  74. doi request reprint Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis
    Celeste B Burness
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    CNS Drugs 28:373-87. 2014
    ....
  75. doi request reprint Miglustat: a review of its use in Niemann-Pick disease type C
    Katherine A Lyseng-Williamson
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:61-74. 2014
    ....
  76. doi request reprint Zonisamide: a review of its use as adjunctive therapy in the management of partial seizures in pediatric patients aged ≥6 years
    Sheridan M Hoy
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Paediatr Drugs 16:235-46. 2014
    ..Thus, oral zonisamide as an adjunctive therapy to other AEDs provides a useful option in the treatment of pediatric patients aged ≥6 years with partial seizures...
  77. doi request reprint Nivolumab: a review of its use in patients with malignant melanoma
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1233-9. 2014
    ..Thus, nivolumab is an emerging, promising option for the treatment of malignant melanoma. ..
  78. doi request reprint Etanercept: a review of its use in autoimmune inflammatory diseases
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1379-410. 2014
    ..This article reviews the extensive clinical experience with etanercept in these patient populations...
  79. doi request reprint Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:75-82. 2015
    ..While more data are needed to confirm the efficacy of alectinib and to evaluate its activity in crizotinib-resistant disease, the drug provides a very promising option for the treatment of ALK-rearranged advanced NSCLC. ..
  80. doi request reprint Omalizumab: a review of its use in patients with chronic spontaneous urticaria
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1693-9. 2014
    ..Thus, omalizumab is an effective and well-tolerated add-on therapy in patients with chronic spontaneous urticaria who are symptomatic despite background therapy with H1 antihistamines. ..
  81. doi request reprint Clevidipine: a review of its use for managing blood pressure in perioperative and intensive care settings
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1947-60. 2014
    ..In conclusion, intravenous clevidipine is a valuable agent for the management of BP in perioperative and intensive care settings. ..
  82. doi request reprint 10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children
    Greg L Plosker
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Paediatr Drugs 16:425-44. 2014
    ..PHiD-CV has a safety and reactogenicity profile similar to that of other pneumococcal conjugate vaccines. ..
  83. doi request reprint Umeclidinium/vilanterol: a review of its use as maintenance therapy in adults with chronic obstructive pulmonary disease
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:61-74. 2015
    ..Thus, inhaled umeclidinium/vilanterol extends the treatment options currently available for the maintenance treatment of adults with COPD and has the convenience of once-daily administration. ..
  84. doi request reprint Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1801-16. 2014
    ..In conclusion, tiotropium Respimat(®) Soft Mist™ Inhaler is a useful option for the treatment of patients with COPD. ..
  85. doi request reprint Linagliptin: an update of its use in patients with type 2 diabetes mellitus
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1927-46. 2014
    ..Meanwhile, the low risk of hypoglycaemia and the nonrenal route of elimination may provide important advantages for some patient groups, including elderly or renally impaired patients. ..
  86. doi request reprint Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome)
    Katherine A Lyseng-Williamson
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 28:465-75. 2014
    ..In the absence of a cure, GALNS enzyme replacement therapy with elosulfase alfa is an important achievement in the treatment of MPS IVA. ..
  87. doi request reprint Empagliflozin: a review of its use in patients with type 2 diabetes mellitus
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1769-84. 2014
    ..This article reviews the pharmacological properties and clinical use of empagliflozin in patients with type 2 diabetes. ..
  88. doi request reprint Dabigatran etexilate: a review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1785-800. 2014
    ....
  89. doi request reprint Omega-3 carboxylic acids (Epanova): a review of its use in patients with severe hypertriglyceridemia
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Am J Cardiovasc Drugs 14:393-400. 2014
    ....
  90. doi request reprint Ferric carboxymaltose: a review of its use in iron deficiency
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:101-27. 2015
    ..In conclusion, ferric carboxymaltose is an important option for the treatment of iron deficiency. ..
  91. doi request reprint Bevacizumab: a review of its use in advanced cancer
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1891-925. 2014
    ..In conclusion, bevacizumab remains an important option for use in patients with advanced cancer. ..
  92. doi request reprint Eltrombopag: a review of its use in the treatment of thrombocytopenia in patients with chronic hepatitis C
    Celeste B Burness
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1961-71. 2014
    ..Eltrombopag provides a new treatment option for thrombocytopenia in patients with chronic HCV infection to allow for optimal antiviral therapy. ..
  93. doi request reprint Vortioxetine: a review of its use in major depressive disorder
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    CNS Drugs 28:855-74. 2014
    ..Vortioxetine extends the available treatment options for patients with MDD, and further investigation into its comparative efficacy versus other antidepressants will allow for more accurate placement among these treatment options. ..
  94. doi request reprint Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1523-42. 2014
    ..Therefore, ceftobiprole medocaril monotherapy offers a simplified option for the initial empirical treatment of patients with HAP (excluding VAP) and in those with CAP requiring hospitalization. ..
  95. doi request reprint Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:2065-78. 2014
    ..Riociguat is a promising addition to the treatment options for patients with CTEPH or PAH. ..
  96. doi request reprint OnabotulinumtoxinA (Botox(®)): a review of its use in the treatment of urinary incontinence in patients with multiple sclerosis or subcervical spinal cord injury
    Mark Sanford
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1659-72. 2014
    ..Intradetrusor onabotulinumtoxinA represents a clinically important advance in the therapy of UI in patients with MS or SCI who have not responded to antimuscarinics or who are unable to tolerate antimuscarinics. ..
  97. doi request reprint Cabozantinib: a review of its use in patients with medullary thyroid cancer
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1435-44. 2014
    ..Although final overall survival data are awaited, current evidence suggests cabozantinib to be a valuable treatment option for adults with progressive, unresectable locally advanced or metastatic MTC...
  98. doi request reprint Fidaxomicin: a review of its use in patients with Clostridium difficile infection
    Lesley J Scott
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1733-47. 2013
    ..Albeit further clinical experience is required to fully define the position of fidaxomicin, it is a valuable emerging option for the treatment of first episode and recurrent episodes of C. difficile-associated diarrhoea...
  99. doi request reprint Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Review of Its Use in HIV Infection
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2079-95. 2014
    ....
  100. doi request reprint Levomilnacipran extended-release: a review of its use in adult patients with major depressive disorder
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    CNS Drugs 28:1071-82. 2014
    ..This article summarizes the clinical use of oral levomilnacipran ER in adults with MDD, and briefly reviews the pharmacological properties of levomilnacipran. ..
  101. doi request reprint Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis
    Paul L McCormack
    Adis, 41 Centorian Drive, Private Bag 65901 Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1463-81. 2013
    ..As long as the risk of PML is managed effectively, natalizumab is a valuable therapeutic option for adults with highly active relapsing forms of multiple sclerosis...